Page 350 - IJB-8-4

Three-Dimensional Printing Technologies for Drug Delivery Applications
Pharm Sci, 90:47–52. https://doi.org/10.1016/j.ijpharm.2015.07.067
https://doi.org/10.1016/j.ejps.2016.03.013 66. Khaled S, Burley J, Alexander M, et al., 2015, 3D Printing
56. Water JJ, Bohr A, Boetker J, et al., 2015, Three-dimensional of Five-in-one dose Combination Polypill with Defined
Printing of Drug-Eluting Implants: Preparation of an Immediate and Sustained Release Profiles. J Controlled
Antimicrobial Polylactide Feedstock Material. J Pharm Sci, Release, 217:308–14.
104:1099–107. https://doi.org/10.1016/j.jconrel.2015.09.028
https://doi.org/10.1002/jps.24305 67. Olmos-Juste R, Guaresti O, Calvo-Correas T, et al., 2021,
57. Goyanes A, Fina F, Martorana A, et al., 2017, Development Design of Drug-loaded 3D Printing Biomaterial Inks and
of Modified Release 3D Printed Tablets (printlets) with Tailor-made Pharmaceutical forms for Controlled Release.
Pharmaceutical Excipients using Additive Manufacturing. Int Int J Pharm, 609:121124.
J Pharm, 527:21–30. https://doi.org/10.1016/j.ijpharm.2021.121124
https://doi.org/10.1016/j.ijpharm.2017.05.021 68. Wang J, Goyanes A, Gaisford S, et al., 2016, Stereolithographic
58. Zhang J, Feng X, Patil H, et al., 2017, Coupling 3D Printing (SLA) 3D Printing of Oral Modified-release Dosage forms.
with Hot-melt Extrusion to Produce Controlled-release Int J Pharm, 503:207–12.
Tablets. Int J Pharm, 519:186–97. https://doi.org/10.1016/j.ijpharm.2016.03.016
https://doi.org/10.1016/j.ijpharm.2016.12.049 69. Martinez PR, Goyanes A, Basit AW, et al., 2017, Fabrication
59. Sadia M, Sośnicka A, Arafat B, et al., 2016, Adaptation of of Drug-loaded Hydrogels with Stereolithographic 3D
Pharmaceutical Excipients to FDM 3D Printing for the Printing. Int J Pharm, 532:313–7.
Fabrication of Patient-Tailored Immediate Release Tablets. https://doi.org/10.1016/j.ijpharm.2017.09.003
Int J Pharm, 513:659–68. 70. Chen K, Zeng J, Lin G, 2022, Fabrication of 5-Fluorouracil-
https://doi.org/10.1016/j.ijpharm.2016.09.050 loaded Tablets with Hyperbranched Polyester by Digital
60. Li Q, Wen H, Jia D, et al., 2017, Preparation and Investigation Light Processing 3D Printing Technology. Eur Polym J,
of Controlled-release Glipizide Novel Oral Device with 171:111190.
Three-dimensional Printing. Int J Pharm, 525:5–11. https://doi.org/10.1016/j.eurpolymj.2022.111190
https://doi.org/10.1016/j.ijpharm.2017.03.066 71. Fina F, Madla C, Goyanes A, et al., 2018, Fabricating 3D
61. Vo AQ, Zhang J, Nyavanandi D, et al., 2020, Hot Melt Printed Orally Disintegrating Printlets using Selective Laser
Extrusion Paired Fused Deposition Modeling 3D Printing to Sintering. Int J Pharm, 541:101–7.
Develop Hydroxypropyl Cellulose Based Floating Tablets of https://doi.org/10.1016/j.ijpharm.2018.02.015
Cinnarizine. Carbohydr Polym, 246:116519. 72. Fina F, Goyanes A, Gaisford S, et al., 2017, Selective Laser
https://doi.org/10.1016/j.carbpol.2020.116519 Sintering (SLS) 3D Printing of Medicines. Int J Pharm,
62. Patel NG, Serajuddin AT, 2021, Development of FDM 529:285–93.
3D-Printed Tablets with Rapid Drug Release, High Drug- https://doi.org/10.1016/j.ijpharm.2017.06.082
polymer Miscibility and Reduced Printing Temperature by 73. Goyanes A, Kobayashi M, Martínez-Pacheco R, et al., 2016,
Applying the Acid-base Supersolubilization (ABS) Principle. Fused-filament 3D Printing of Drug Products: Microstructure
Int J Pharm, 600:120524. Analysis and Drug Release Characteristics of PVA-based
https://doi.org/10.1016/j.ijpharm.2021.120524 Caplets. Int J Pharm, 514:290–5.
63. Tabriz AG, Nandi U, Hurt AP, et al., 2021, 3D Printed Bilayer https://doi.org/10.1016/j.ijpharm.2016.06.021
Tablet with Dual Controlled Drug Release for Tuberculosis 74. Maroni A, Melocchi A, Parietti F, et al., 2017, 3D Printed
Treatment. Int J Pharm, 593:120147. Multi-compartment Capsular Devices for Two-pulse Oral
https://doi.org/10.1016/j.ijpharm.2020.120147 Drug Delivery. J Controlled Release, 268:10–8.
64. Khaled SA, Burley JC, Alexander MR, et al., 2014, Desktop https://doi.org/10.1016/j.jconrel.2017.10.008
3D Printing of Controlled Release Pharmaceutical Bilayer 75. Genina N, Janßen E, Breitenbach A, et al., 2013, Evaluation
Tablets. Int J Pharm, 461:105–11. of Different Substrates for Inkjet Printing of Rasagiline
https://doi.org/10.1016/j.ijpharm.2013.11.021 Mesylate. Eur J Pharm Biopharm, 85:1075–83.
65. Khaled SA, Burley JC, Alexander MR, et al., 2015, 3D https://doi.org/10.1016/j.ejpb.2013.03.017
Printing of Tablets Containing Multiple Drugs with Defined 76. Genina N, Fors D, Palo M, et al., 2013, Behavior of Printable
Release Profiles. Int J Pharm, 494:643–50. Formulations of Loperamide and Caffeine on Different

342 International Journal of Bioprinting (2022)–Volume 8, Issue 4